First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks
Clinical trial NCT01555125 · COMPLETED
Trial details
- NCT number
- NCT01555125
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-08
- Primary completion
- 2016-10-24
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.